The Lipid-Lowering Efficacy of Switching Within Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients

MLA

Roger Bedimo, et al. “The Lipid-Lowering Efficacy of Switching Within Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients.” American Journal of Infectious Diseases, vol. 4, Feb. 2008, pp. 147–51. EBSCOhost, https://doi.org/10.3844/ajidsp.2008.147.151.

APA

Roger Bedimo, Anita P. Rahman, Maria C. Rodriguez-Barradas, Amy M. Bain, Kenna D. Payne, Anthony J. Busti, & Darego O. Maclayton. (2008). The Lipid-Lowering Efficacy of Switching Within Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients. American Journal of Infectious Diseases, 4, 147–151. https://doi.org/10.3844/ajidsp.2008.147.151

Chicago

Roger Bedimo, Anita P. Rahman, Maria C. Rodriguez-Barradas, Amy M. Bain, Kenna D. Payne, Anthony J. Busti, and Darego O. Maclayton. 2008. “The Lipid-Lowering Efficacy of Switching Within Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients.” American Journal of Infectious Diseases 4 (February): 147–51. doi:10.3844/ajidsp.2008.147.151.